
Results
2
2 companies
MedinCell
Market Cap: €879.8m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€24.50
7D
-1.7%
1Y
48.9%
DBV Technologies
Market Cap: €706.1m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.39
7D
-2.0%
1Y
40.5%